The use of systemic corticosteroids in asthma management in Latin American countries.

"Competing interest Jorge Fernando Maspero has received grants or speaker fees or participated in boards or as an investigator with the following companies: AstraZeneca, GlaxoSmithKline, Sanofi, Novartis, Teva, Menarini, Uriach, and Inmunotek. Alvaro Augusto Cruz has received grants or speaker fees or participated in boards or as an investigator with the following companies: AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Sanofi, Novartis, Mylan, Chiesi, Abdi-Ibrahim, Eurofarma, Mantecorp, Crossject. Felicia Montero-Arias has participated in clinical studies funded by AstraZeneca, Novartis, and the National Institutes of Health. She has also participated in conferences and advisory boards sponsored by AstraZeneca and Novartis. Cesar Fireth Pozo Beltran has participated in conferences and advisory boards sponsored by the following companies: AstraZeneca, GlaxoSmithKline, Sanofi, Sandoz, Alergia Molecular, Bayer, and Nestle. Abraham Ali Munive, Ramses Hernandez Pliego, and Hisham Farouk report no competing interests."

"Funding This publication is supported by AstraZeneca (Cambridge, UK)."